International Journal of Hematology and Oncology
2023, Vol 33, Num 4 Page(s): 051-053
| Back | Table of Contents | Turkish Abstract | PDF | Mail to Author | |
5-Flourouracil–Induced Encephalopathy in Parkinson’s disease
Taner KORKMAZ1, Selcuk SEBER1, Gul BASARAN1, P. Fulden YUMUK1, Faysal DANE1, Muharrem KOCAR1, Ferhat TELLI1, N. Serdar TURHAL1
Marmara Medical University, Department of Medical Oncology, Istanbul, TURKEY
Keywords: Parkinson’s disease, 5-Flourouracil, Rectum cancer, Encephalopathy
A 59 year-old male with Parkinson’s disease developed encephalopathy during adjuvant treatment of rectal cancer. Acute neurotoxicity related to high dose 5-Flourouracil infusion is well described, but encephalopathy with low dose bolus 5-Flourouracil is rare. The advanced Parkinson’s disease patients may be more prone to hyperammonemia associated encephalopathy caused by 5-Flourouracil . The prompt recognition of the symptoms is key to diagnosis and treatment.
Taner KORKMAZ1, Selcuk SEBER1, Gul BASARAN1, P. Fulden YUMUK1, Faysal DANE1, Muharrem KOCAR1, Ferhat TELLI1, N. Serdar TURHAL1
Marmara Medical University, Department of Medical Oncology, Istanbul, TURKEY
Keywords: Parkinson’s disease, 5-Flourouracil, Rectum cancer, Encephalopathy
A 59 year-old male with Parkinson’s disease developed encephalopathy during adjuvant treatment of rectal cancer. Acute neurotoxicity related to high dose 5-Flourouracil infusion is well described, but encephalopathy with low dose bolus 5-Flourouracil is rare. The advanced Parkinson’s disease patients may be more prone to hyperammonemia associated encephalopathy caused by 5-Flourouracil . The prompt recognition of the symptoms is key to diagnosis and treatment.
| Back | Table of Contents | Turkish Abstract | PDF | Mail to Author | |